Expression of CD44 and the survival in glioma: a meta-analysis

Background: Higher tumor expression of CD44, a marker of cancer stem cells (CSCs), is associated with poor overall survival (OS) in various cancers. However, the association between CD44 and poor OS remains inconsistent in glioma. We aimed to evaluate the potential predictive role of CD44 for progno...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Gang, Song, Xinghui, Liu, Jun, Li, Shize, Gao, Weiqin, Qiu, Mingxing, Yang, Changjin, Ma, Yiming, Chen, Yuhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2020
Materias:
Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7160241/
https://www.ncbi.nlm.nih.gov/pubmed/32232385
http://dx.doi.org/10.1042/BSR20200520

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7160241/
https://www.ncbi.nlm.nih.gov/pubmed/32232385
http://dx.doi.org/10.1042/BSR20200520

Ejemplares similares